Authors:
HOLMES FA
LOPEZ A
MAVLIGIT G
FRASCHINI G
FRYE D
HORTOBAGYI GN
Citation: Fa. Holmes et al., SECONDARY DRUG-RESISTANCE IN BREAST-CANCER - FAILURE TO REVERSE WITH ORAL NIFEDIPINE, International journal of cancer, 73(2), 1997, pp. 184-186
Authors:
RAHMAN Z
ESPARZAGUERRA L
YAP HY
FRASCHINI G
BODEY G
HORTOBAGYI G
Citation: Z. Rahman et al., CHEMOTHERAPY-INDUCED NEUTROPENIA AND FEVER IN PATIENTS WITH METASTATIC BREAST-CARCINOMA RECEIVING SALVAGE CHEMOTHERAPY, Cancer, 79(6), 1997, pp. 1150-1157
Authors:
HOLMES FA
MADDEN T
NEWMAN RA
VALERO V
THERIAULT RL
FRASCHINI G
WALTERS RS
BOOSER DJ
BUZDAR AU
WILLEY J
HORTOBAGYI GN
Citation: Fa. Holmes et al., SEQUENCE-DEPENDENT ALTERATION OF DOXORUBICIN PHARMACOKINETICS BY PACLITAXEL IN A PHASE-I STUDY OF PACLITAXEL AND DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2713-2721
Authors:
HOFFMAN K
HOLMES FA
FRASCHINI G
ESPARZA L
FRYE D
RABER MN
NEWMAN RA
HORTOBAGYI GN
Citation: K. Hoffman et al., PHASE I-II STURDY - TRICIRIBINE (TRICYCLIC NUCLEOSIDE PHOSPHATE) FOR METASTATIC BREAST-CANCER, Cancer chemotherapy and pharmacology, 37(3), 1996, pp. 254-258
Authors:
DHINGRA K
FRYE D
NEWMAN RA
WALTERS R
THERIAULT R
FRASCHINI G
SMITH T
BUZDAR A
HORTOBAGYI GN
Citation: K. Dhingra et al., PHASE-II CLINICAL AND PHARMACOLOGICAL STUDY OF PIRARUBICIN IN COMBINATION WITH 5-FLUOROURACIL AND CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER, Clinical cancer research, 1(7), 1995, pp. 691-697
Authors:
VALERO V
HOLMES FA
WALTERS RS
THERIAULT RL
ESPARZA L
FRASCHINI G
FONSECA GA
BELLET RE
BUZDAR AU
HORTOBAGYI GN
Citation: V. Valero et al., PHASE-II TRIAL OF DOCETAXEL - A NEW, HIGHLY EFFECTIVE ANTINEOPLASTIC AGENT IN THE MANAGEMENT OF PATIENTS WITH ANTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER, Journal of clinical oncology, 13(12), 1995, pp. 2886-2894
Authors:
BARBARINI G
FERRARI G
FRASCHINI G
GUIDA A
BISSOLATI M
GATTI M
CHIESA A
GARAVELLI G
Citation: G. Barbarini et al., PREVALENCE OF ANTI-HCV ANTIBODIES IN HEALTHY-SUBJECTS WITHOUT RISK-FACTORS FOR BLOOD-BORNE VIRAL-INFECTIONS, Hepatology, 22(4), 1995, pp. 1142-1142